IMMUTEP Ltd
IMMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506184
No open-market purchases or sales by IMMUTEP Ltd insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $692.0K in total; no superinvestor holds it.
Other share classesPRRUF
- Currency
- AUD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 24, 2026, 1:07 AM ET
Amounts are in AUD, the currency IMMUTEP Ltd reports in. Lines marked ≈ US$ convert key figures to US dollars.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 |
| Filing | 20-F | 20-F | 20-F | 20-F | 20-F |
| Reported | – | – | – | – | – |
| Revenue | AUD 10.3M≈ US$6.69M | AUD 7.84M≈ US$5.14M | AUD 5.20M≈ US$3.50M | AUD 6.76M≈ US$4.90M | AUD 3.97M≈ US$2.96M |
| Research and development | AUD 49.8M | AUD 31.5M | AUD 28.8M | AUD 25.3M | AUD 12.0M |
| Selling, general and administrative | AUD 8.64M | AUD 8.85M | AUD 8.68M | AUD 7.21M | AUD 6.28M |
| Interest expense | AUD 37.1K | AUD 30.6K | AUD 20.4K | AUD 92.4K | AUD 9.82K |
| Income tax | AUD 0 | AUD 0 | AUD 0 | AUD 34 | AUD 33 |
| Net income | AUD -61.4M≈ US-$39.8M | AUD -42.7M≈ US-$28.0M | AUD -39.9M≈ US-$26.9M | AUD -32.2M≈ US-$23.4M | AUD -29.9M≈ US-$22.3M |
| EPS, basic | AUD -0.0422 | AUD -0.0356 | AUD -0.0447 | AUD -0.0379 | AUD -5.03 |
| EPS, diluted | AUD -0.0422 | AUD -0.0356 | AUD -0.0447 | AUD -0.0379 | AUD -5.03 |
| Weighted shares, basic | 1.46B | 1.20B | 892.4M | 849.0M | 594.9M |
| Weighted shares, diluted | 1.46B | 1.20B | 892.4M | 849.0M | 594.9M |
| Margins and growth | |||||
| Net margin | -594.6% | -545.0% | -767.2% | -476.6% | -753.6% |
| Revenue growth, year over year | +31.8% | +50.7% | −23.1% | +70.3% | −76.0% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 |
| Filing | 20-F | 20-F | 20-F | 20-F | 20-F |
| Reported | – | – | – | – | – |
| Cash and equivalents | AUD 67.4M | AUD 161.8M | AUD 123.4M | AUD 80.0M | AUD 60.6M |
| Accounts receivable | AUD 9.87M | AUD 7.35M | AUD 7.95M | AUD 8.37M | AUD 6.12M |
| Total current assets | AUD 149.1M | AUD 191.4M | AUD 135.0M | AUD 90.8M | AUD 68.4M |
| Property, plant and equipment | AUD 63.5K | AUD 63.1K | AUD 83.1K | AUD 37.9K | AUD 40.9K |
| Intangible assets | AUD 7.20M | AUD 8.24M | AUD 9.49M | AUD 10.6M | AUD 12.8M |
| Total assets | AUD 157.0M≈ US$103.2M | AUD 201.6M≈ US$134.6M | AUD 147.4M≈ US$98.2M | AUD 102.2M≈ US$70.5M | AUD 82.0M≈ US$61.5M |
| Accounts payable | AUD 10.6M | AUD 9.56M | AUD 9.02M | AUD 5.75M | AUD 4.78M |
| Total current liabilities | AUD 12.8M | AUD 10.5M | AUD 9.77M | AUD 6.41M | AUD 5.34M |
| Total liabilities | AUD 13.3M | AUD 12.1M | AUD 11.0M | AUD 8.09M | AUD 8.76M |
| Shareholders' equity | AUD 143.6M | AUD 189.5M | AUD 136.5M | AUD 94.1M | AUD 73.3M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 |
| Filing | 20-F | 20-F | 20-F | 20-F | 20-F |
| Reported | – | – | – | – | – |
| Operating cash flow | AUD -62.0M≈ US-$40.2M | AUD -34.8M≈ US-$22.8M | AUD -35.4M≈ US-$23.8M | AUD -30.2M≈ US-$21.9M | AUD -17.6M≈ US-$13.2M |
| Capital expenditures | AUD 45.8K | AUD 29.2K | AUD 82.7K | AUD 22.9K | AUD 15.6K |
| Free cash flow | AUD -62.1M≈ US-$40.2M | AUD -34.9M≈ US-$22.8M | AUD -35.4M≈ US-$23.9M | AUD -30.3M≈ US-$22.0M | AUD -17.7M≈ US-$13.2M |
| Depreciation and amortization | AUD 2.39M | AUD 2.26M | AUD 2.06M | AUD 2.06M | AUD 2.07M |
| Stock-based compensation | AUD 1.16M | AUD 1.80M | AUD 2.00M | AUD 1.49M | AUD 1.70M |
| Investing cash flow | AUD -38.5M | AUD -21.0M | AUD -82.7K | AUD -22.9K | AUD -15.6K |
| Financing cash flow | AUD -525.1K | AUD 95.2M | AUD 76.0M | AUD 50.3M | AUD 52.7M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 11.3% | 22.9% | 38.5% | 22.0% | 42.9% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Jun 30, 2026 | 1.47B | +0.9% | SEC |
| Jun 30, 2025 | 1.46B | +0.5% | SEC |
| Jun 30, 2024 | 1.45B | +22.3% | SEC |
| Jun 30, 2023 | 1.19B | +37.1% | SEC |
| Jun 30, 2022 | 866.2M | +15.8% | SEC |
| Jun 30, 2021 | 748.2M | +53.4% | SEC |
| Jun 30, 2020 | 487.6M | −85.6% | SEC |
| Jun 30, 2019 | 3.39B | +12.0% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
- ≈ US$ figures convert AUD at FRED H.10 exchange rates (Federal Reserve): the average rate over the period for income and cash flow, and the rate on the period-end date, or the last business day before it, for the balance sheet.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.